Iteos Therapeutics Inc (ITOS)
Iteos Therapeutics Inc (ITOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -38,216 | -112,642 | -82,091 | -49,851 | -15,551 |
| Depreciation Amortization | -2,436 | -9,336 | 671 | -4,939 | 222 |
| Accounts receivable | -942 | -2,385 | -119 | -145 | 554 |
| Accounts payable and accrued liabilities | -5,551 | 3,036 | -4,581 | -2,512 | -2,104 |
| Other Working Capital | 989 | -8,799 | -20,357 | -14,082 | -14,181 |
| Other Operating Activity | 13,756 | 26,370 | 16,486 | 15,428 | 4,505 |
| Operating Cash Flow | $-32,400 | $-103,756 | $-89,991 | $-56,101 | $-26,555 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -99 | -83 | -819 | N/A |
| PPE Investments | -945 | -2,966 | -1,570 | N/A | -119 |
| Purchase Of Investment | -155,852 | -290,541 | -193,510 | -139,037 | -52,575 |
| Sale Of Investment | 87,197 | 366,264 | 206,265 | 128,265 | 21,000 |
| Investing Cash Flow | $-69,600 | $72,658 | $11,102 | $-11,591 | $-31,694 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 22 | 1,113 | 806 | 796 | 578 |
| Financing Cash Flow | $22 | $1,113 | $806 | $796 | $578 |
| Exchange Rate Effect | -2,554 | -3,602 | -2,554 | -1,659 | -1,771 |
| Beginning Cash Position | 251,451 | 285,038 | 285,038 | 285,038 | 285,038 |
| End Cash Position | 146,919 | 251,451 | 204,401 | 216,483 | 225,596 |
| Net Cash Flow | $-104,532 | $-33,587 | $-80,637 | $-68,555 | $-59,442 |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,400 | -103,756 | -89,991 | -56,101 | -26,555 |
| Capital Expenditure | -945 | -2,966 | -1,570 | N/A | -119 |
| Free Cash Flow | -33,345 | -106,722 | -91,561 | -56,101 | -26,674 |